Structural, Visual and Refractive Outcomes of Intravitreal Aflibercept Injection in High-Risk Prethreshold Type 1 Retinopathy of Prematurity

Publisher： Karger

E-ISSN： 1423-0259|53|1|15-20

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.53, Iss.1, 2014-11, pp. : 15-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly

By  

Case Reports in Ophthalmology, Vol. 5, Iss. 3, 2014-10 ,pp. : 318-324

Karger

Access to resources Recommend Favorite

One-Year Outcomes of 1 + pro re nata versus 3 + pro re nata Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 237, Iss. 2, 2017-02 ,pp. : 105-110

Karger

Access to resources Recommend Favorite

Risk Factors in Retinopathy of Prematurity

By  

Ophthalmologica, Vol. 214, Iss. 2, 2000-03 ,pp. : 131-135

Karger

Access to resources Recommend Favorite

Structural and Functional Assessment of Macula in Patients with High-Risk Proliferative Diabetic Retinopathy Submitted to Panretinal Photocoagulation and Associated Intravitreal Bevacizumab Injections: A Comparative, Randomised, Controlled Trial

By  

Ophthalmologica, Vol. 230, Iss. 1, 2013-05 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Risk Factors for Acute Retinopathy of Prematurity

By  

Annals of Ophthalmology, Vol. 39, Iss. 2, 2007-06 ,pp. : 107-111

Humana Press, Inc

Access to resources Recommend Favorite